methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate

C39H47N7O7S — CID 135123593

IUPACmethyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate
SMILESCCC1CN(Cc2cc(C(c3ccc4c(nnn4CC)c3C)C(C)(C)C(=O)Nc3cnc(OCC(=O)OC)nc3)ccc2C)S(O)(O)c2ccccc2O1
InChIInChI=1S/C39H47N7O7S/c1-8-29-22-45(54(49,50)33-13-11-10-12-32(33)53-29)21-27-18-26(15-14-24(27)3)35(30-16-17-31-36(25(30)4)43-44-46(31)9-2)39(5,6)37(48)42-28-19-40-38(41-20-28)52-23-34(47)51-7/h10-20,29,35,49-50H,8-9,21-23H2,1-7H3,(H,42,48)
InChIKeyMHYAQOPGHALTFW-UHFFFAOYSA-N
MW757.91 g/mol
LogP6.90
Rot. Bonds12

About methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate

methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate (PubChem CID 135123593) has the molecular formula C39H47N7O7S and a molecular weight of 757.91 g/mol. Its IUPAC name is methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate.

Molecular Properties

Compound Namemethyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate
PubChem CID135123593
Molecular FormulaC39H47N7O7S
Molecular Weight757.91 g/mol
Exact Mass757.33
IUPAC Namemethyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate
SMILESCCC1CN(Cc2cc(C(c3ccc4c(nnn4CC)c3C)C(C)(C)C(=O)Nc3cnc(OCC(=O)OC)nc3)ccc2C)S(O)(O)c2ccccc2O1
InChIInChI=1S/C39H47N7O7S/c1-8-29-22-45(54(49,50)33-13-11-10-12-32(33)53-29)21-27-18-26(15-14-24(27)3)35(30-16-17-31-36(25(30)4)43-44-46(31)9-2)39(5,6)37(48)42-28-19-40-38(41-20-28)52-23-34(47)51-7/h10-20,29,35,49-50H,8-9,21-23H2,1-7H3,(H,42,48)
InChIKeyMHYAQOPGHALTFW-UHFFFAOYSA-N
XLogP6.90
TPSA174.05 Ų
H-Bond Donors3
H-Bond Acceptors13
Rotatable Bonds12
Heavy Atoms54
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500757.91
LogP ≤ 56.90
H-Bond Donors ≤ 53
H-Bond Acceptors ≤ 1013

Analyze methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate?
The IUPAC name of methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate (CID 135123593) is methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate.
What is the SMILES notation for methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate?
The canonical SMILES for methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate is CCC1CN(Cc2cc(C(c3ccc4c(nnn4CC)c3C)C(C)(C)C(=O)Nc3cnc(OCC(=O)OC)nc3)ccc2C)S(O)(O)c2ccccc2O1.
What is the InChIKey of methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate?
The InChIKey is MHYAQOPGHALTFW-UHFFFAOYSA-N. The full InChI is InChI=1S/C39H47N7O7S/c1-8-29-22-45(54(49,50)33-13-11-10-12-32(33)53-29)21-27-18-26(15-14-24(27)3)35(30-16-17-31-36(25(30)4)43-44-46(31)9-2)39(5,6)37(48)42-28-19-40-38(41-20-28)52-23-34(47)51-7/h10-20,29,35,49-50H,8-9,21-23H2,1-7H3,(H,42,48).
What are the key properties of methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate?
methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate has a molecular weight of 757.91 g/mol, XLogP of 6.90, 12 rotatable bonds, 3 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for methyl 2-[5-[[3-[3-[(4-ethyl-1,1-dihydroxy-3,4-dihydro-5,1λ4,2-benzoxathiazepin-2-yl)methyl]-4-methylphenyl]-3-(1-ethyl-4-methylbenzotriazol-5-yl)-2,2-dimethylpropanoyl]amino]pyrimidin-2-yl]oxyacetate is sourced from PubChem (CID 135123593), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).